NASDAQ
NLS Pharmaceutics AG (NLSP) has a fcf yield of -268.86% as of Monday, August 3, 2026. This represents a 22015.10% decrease compared to its 12-month average of -1.22%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.